Drug
Paromomycin clinical trials
- studies test it
- 17
- open now
- 2
- in phase 3
- 10
- first study started
- 1994
Keep track of what changes. Save the Paromomycin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Other names
Studies by the year they started
14 studies that test it; most in 2007 (2); 1 more planned to start later
| Year | Studies |
|---|---|
| 1994 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 4
- Phase 3
- 10
- Phase 4
- 1
- No phase
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 17
Drugs for Neglected Diseases (4) · PATH (3) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Fundacion Nacional de Dermatologia (2) · Banaras Hindu University (2) · U.S. Army Medical Research and Development Command (1) · FDA Office of Orphan Products Development (1) · Institute of Tropical Medicine, Belgium (1)
Often tested with
Tested in the same studies.
Miltefosine (5) · Liposomal amphotericin B (5) · Amphotericin B (5) · WR 279 (1) · Streptomycin (1) · Pentamidine (1) · Interleukin-12 (1) · Azithromycin (1)
Studies
Open first, then newest update. How each study uses Paromomycin is read from its arms, and is right about nine times in ten.
Testing it · 17
- Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)Not yet recruitingPhase 3Institute of Tropical Medicine, BelgiumNCT07463040Written as Miltefosine + Paromomycin
- Paromomycin or Metronidazole for Symptomatic Dientamoeba Fragilis in AdultsRecruitingNot applicableSheba Medical CenterNCT06907498Written as Paromomycin
- A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3CompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00000771Written as Paromomycin sulfate
- Topical Paromomycin for Cutaneous Leishmaniasis in BoliviaCompletedPhase 2/3Fundacion Nacional de DermatologiaNCT03096457Written as Paromomycin Sulfate
- Oral Miltefosine Plus Topical Paromomycin In American Cutaneous LeishmaniasisCompletedPhase 2/3Fundacion Nacional de DermatologiaNCT03829917Written as Miltefosine and Paromomycin
- Short Course Regimens for Treatment of PKDL (Sudan)Status unknownPhase 2Drugs for Neglected DiseasesNCT03399955Written as Paromomycin
- Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in PanamaCompletedPhase 3U.S. Army Medical Research and Development CommandNCT01790659Written as Paromomycin
- Treatment of Chronic Cryptosporidiosis in AIDS PatientsTerminatedNot applicableNational Institute of Allergy and Infectious Diseases (NIAID)NCT00001128Written as Paromomycin sulfate
- Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V LeishmaniasisCompletedPhase 3Drugs for Neglected DiseasesNCT00255567Written as Paromomycin sulphate
- Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in BangladeshCompletedPhase 3Drugs for Neglected DiseasesNCT01122771Written as liposomal amphotericin B + paromomycin
- Pilot Randomized Study of Paromomycin (Aminosidine) vs Streptomycin for Uncomplicated Pulmonary TuberculosisCompletedNot applicableFDA Office of Orphan Products DevelopmentNCT00004444Written as paromomycin
- Safety and Efficacy Study of Paromomycin to Treat Visceral LeishmaniasisCompletedPhase 3PATHNCT00216346Written as Paromomycin sulfate
- Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral LeishmaniasisCompletedPhase 4PATHNCT00604955Written as Paromomycin sulfate
- An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in BangladeshCompletedNot applicablePATHNCT01328457Written as Paromomycin sulfate
- Combination Therapy in Indian Visceral LeishmaniasisCompletedPhase 3Banaras Hindu UniversityNCT00523965Written as Liposomal Amphotericin B and Paromomycin Sulfate
- Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral LeishmaniasisCompletedPhase 3Drugs for Neglected DiseasesNCT00696969Written as Ambisome and Paromomycin
- An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral LeishmaniasisCompletedPhase 3Banaras Hindu UniversityNCT00629031Written as Paromomycin
Given in every arm · 2 — Paromomycin is usual care beside what is tested
- Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern AfricaCompletedPhase 3Drugs for Neglected DiseasesNCT03129646Written as Paromomycin
- Efficacy of Topical Liposomal Form of Drugs in Cutaneous LeishmaniasisCompletedEarly Phase 1Tehran University of Medical SciencesNCT01050777Written as Liposomal Paromomycin
As the comparator · 1 — what is tested is compared with Paromomycin
Codes
What other systems call Paromomycin · ClinicalTrials.gg INT007960
- MeSH (NLM) D010303ParomomycinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 61JJC8N5ZKPAROMOMYCINConfirmed FDA, NLM, Wikidata
- RxNorm 7934Confirmed FDA, Wikidata
- Wikidata Q415625paromomycinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61878ParomomycinOne source FDA
- DrugBank DB01421One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D010303 | Paromomycin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 61JJC8N5ZK | PAROMOMYCIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 7934 | — | Confirmed FDA, Wikidata |
| Wikidata | Q415625 | paromomycin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61878 | Paromomycin | One source FDA |
| DrugBank | DB01421 | — | One source Wikidata |
Also registered as paromomycin sulfate (UNII 845NU6GJPS · RxNorm 66912).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.